Isolation, analysis and in vitro assessment of CYP3A4 inhibition by methylxanthines extracted from Pu-erh and Bancha tea leaves KD Georgiev, M Radeva-Ilieva, S Stoeva, I Zhelev Scientific Reports 9 (1), 13941, 2019 | 24 | 2019 |
Protective effect of methylxanthine fractions isolated from Bancha tea leaves against doxorubicin-induced cardio-and nephrotoxicities in rats MP Radeva-Ilieva, KD Georgiev, NR Hvarchanova, SS Stoeva, IJ Slavov, ... BioMed Research International 2020, 2020 | 9 | 2020 |
In vitro inhibitions of CYP2C9 and CYP3A4 by fractions isolated from Goji berry (Lycium barbarum) fruits K Georgiev, M Radeva-Ilieva Scripta Scientifica Pharmaceutica 6 (1), 26-30, 2019 | 5 | 2019 |
Intravenous lipid infusion in toxicological practice P Marinov, D Ivanov, S Zlateva, S Dimitrova, G Kehayova, M Radeva Scripta Scientifica Pharmaceutica 5 (1), 7-13, 2018 | 5 | 2018 |
A HPLC-UV method for analysis of total plant extract and catechin fraction of Bancha green tea S Stoeva, M Radeva–Ilieva, I Zhelev, K Georgiev The Natural Products Journal 13 (2), 90-97, 2023 | 3 | 2023 |
Intravenous lipid emulsion infusion in acute intoxication with fenitrothion P Marinov, D Ivanov, S Zlateva, S Dimitrova, G Kehayova, M Radeva, ... Scripta Scientifica Pharmaceutica 5 (1), 47-50, 2018 | 3 | 2018 |
Modulation of CYP3A4 by the RGD-and Neurotensin (8-13)-analogues K Georgiev, M Radeva, A Balacheva, S Michaylova, T Pajpanova European Peptide Society & PSP, 215-216, 2018 | 2 | 2018 |
Cardio- and nephroprotective effects of fractions isolated from Lycium barbarum (goji berry) in models of cardio- and nephrotoxicity in rats N Hvarchanova, S Stoeva, M Radeva-Ilieva, I Zhelev, M Georgieva, ... Biotechnology & Biotechnological Equipment 37 (1), 64-73, 2023 | 1 | 2023 |
Influence of methylxanthines isolated from Bancha green tea on the pharmacokinetics of sildenafil in rats M Radeva-Ilieva, S Stoeva, N Hvarchanova, I Zhelev, KD Georgiev DARU Journal of Pharmaceutical Sciences, 1-10, 2022 | 1 | 2022 |
INNs granted with specific storage requirements in Bulgarian pharmacies. Part 2: Antineoplastic and immunomodulating agents E Grigorov, M Radeva-Ilieva, KD Georgiev Pharmacia 70 (4), 837-845, 2023 | | 2023 |
INNs granted with specific storage requirements in Bulgarian pharmacies. Part 1: Medicines acting on cardiovascular and nervous system E Grigorov, M Radeva-Ilieva, KD Georgiev Pharmacia 70 (3), 689-697, 2023 | | 2023 |
A review of clinically significant interactions between medicines and green tea M Radeva-Ilieva Varna Medical Forum 12 (2), 2023 | | 2023 |
ROLE OF THE HOSPITAL PHARMACIST IN PREVENTING DRUG INTERACTIONS IN CLINICAL PRACTICE M Radeva-Ilieva Annual for Hospital Pharmacy 9 (1), 2023 | | 2023 |
A REVIEW OF CANCER IMMUNOTHERAPY: IMMUNE CHECKPOINT INHIBITORS M Radeva-Ilieva Annual for Hospital Pharmacy 9 (1), 2023 | | 2023 |
New pharmacotherapeutic options for the treatment of heart failure with reduced ejection fraction. N Hvarchanova, S Stoeva, M Radeva-Ilieva, M Georgieva | | 2021 |
Нови фармакотерапевтични подходи за лечение на хроничната сърдечна недостатъчност с редуцирана фракция на изтласкване М Георгиева, Н Хвърчанова, С Стоева, М Радева-Илиева Сърдечно-съдови заболявания 52 (2), 9-17, 2021 | | 2021 |
The Sea–A Source Of Bioactive Substances N Hvarchanova, M Georgieva, M Radeva-Ilieva, S Stoeva, K Georgiev Varna Medical Forum 9 (1), 34-39, 2020 | | 2020 |
Application Of A Physiologically-Based Pharmacokinetic (PBPK) Model In Predicting Drug Interactions M Radeva-Ilieva, K Georgiev Annual for Hospital Pharmacy 6 (1), 25-32, 2020 | | 2020 |
Potential Drug-Drug Interactions With Tyrosine Kinase Inhibitors M Radeva-Ilieva, B Kirilov, K Georgiev Annual for Hospital Pharmacy 5 (1), 55-62, 2019 | | 2019 |
Evaluation of Laktera nature® potential to modulate the function of CYP3A4 isoenzyme N Hvarchanova, K Georgiev, M Radeva-Ilieva, M Georgieva 4th International Conference on National Products Utilization (ICNPU), 29 …, 2019 | | 2019 |